Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Pain (Nabumetone - Pain & inflammation - musculoskeletal)

Records returned : 22 (on 01 Jun 2025 at 18:44:01). Return to search results for ' Pain '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Nabumetone

Drug:

Nabumetone

Indication :

Pain & inflammation - musculoskeletal

Status :

Non Formulary

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

2. Celecoxib

Drug:

Celecoxib

Indication :

Pain & inflammation - musculoskeletal

Status :

Green

Formulations :

Capsules

Restrictions / Comments:

Important

Preferred

Preferred COX II inhibitor for licensed indications

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

3. Diclofenac sodium

Drug:

Diclofenac sodium

Indication :

Pain & inflammation - musculoskeletal

Status :

Green

Formulations :

Suppositories

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

6. Diclofenac sodium

Drug:

Diclofenac sodium

Indication :

Pain & inflammation - musculoskeletal

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Ibuprofen or naproxen are the preferred NSAIDS. Diclofenac for use if 1st-line options are ineffective / not tolerated. Restriced at Trusts to Rheumatology only.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

7. Diclofenac sodium

Drug:

Diclofenac sodium

Indication :

Pain & inflammation - musculoskeletal

Status :

Green (see narrative)

Formulations :

Injection

Restrictions / Comments:

Important

Restricted to use when oral NSAIDs are not an option.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

15. Diclofenac sodium

Drug:

Diclofenac sodium

Indication :

Pain & inflammation - musculoskeletal

Status :

Non Formulary

Formulations :

Modified release capsules
Modified release tablets

Restrictions / Comments:

Important

Ibuprofen or naproxen are the preferred NSAIDS. Standard release diclofenac may be considered if 1st-line NSAIDs are ineffective / not tolerated.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

4. Ibuprofen

Drug:

Ibuprofen

Indication :

Pain & inflammation - musculoskeletal

Status :

Green

Formulations :

Oral suspension
Tablets

Restrictions / Comments:

Preferred

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

9. Ibuprofen

Drug:

Ibuprofen

Indication :

Pain & inflammation - musculoskeletal

Status :

Green (see narrative)

Formulations :

Oro-dispersible

Restrictions / Comments:

Important

Reserved for patients with swallowing difficulties

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

12. Ibuprofen

Drug:

Ibuprofen

Indication :

Pain & inflammation - musculoskeletal

Status :

Red

Formulations :

Infusion

Restrictions / Comments:

Important

Restricted for patients where an oral NSAID is not suitable

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

18. Ibuprofen

Drug:

Ibuprofen

Indication :

Pain & inflammation - musculoskeletal

Status :

Non Formulary

Formulations :

Capsules
Modified release capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

5. Naproxen

Drug:

Naproxen

Indication :

Pain & inflammation - musculoskeletal

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Preferred

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

11. Naproxen

Drug:

Naproxen

Indication :

Pain & inflammation - musculoskeletal

Status :

Green (see narrative)

Formulations :

Effervescent tablets
Oral suspension

Restrictions / Comments:

Important

Effervescent tablets and oral suspension are much more expensive and should be reserved for patients in whom ibuprofen suspension is not suitable. Reserve oral suspension for patients with sodium restriction or for children.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :